OTCMKTS:DNAG DNAPrint Genomics (DNAG) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free DNAG Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get DNAPrint Genomics alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About DNAPrint Genomics Stock (OTCMKTS:DNAG)DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> DNAG Stock News HeadlinesApril 9, 2024 | tmcnet.comDovetail Genomics Introduces Novel LinkPrep™ NGS Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingApril 7, 2024 | msn.comResearchers develop first genetic maps for disease-linked DNA repeatsApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 26, 2024 | msn.comNucleus Genomics Introduces DNA Analysis Product for Personalized MedicineMarch 6, 2024 | msn.comNew interdisciplinary center aims to spark developments in synthetic genomicsFebruary 11, 2024 | benzinga.comDNA Print Genomics Stock (OTC:DNAG) Dividends: History, Yield and DatesJanuary 19, 2024 | msn.comMyriad Genetics to acquire certain assets from Intermountain Precision GenomicsJanuary 8, 2024 | msn.comBionano Genomics expects Q4 revenue growth of 27% to 30%April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.December 26, 2023 | msn.comNew Genomics Databases Could Drive Major BreakthroughsDecember 20, 2023 | msn.comRevealing close and distant relatives in ancient DNA with unprecedented precisionDecember 14, 2023 | msn.comDNA discovery opens door to personalised medicine for Indigenous AustraliansDecember 4, 2023 | tmcnet.comSABCS23: Reveal Genomics® Unleashes Groundbreaking DNADX® Liquid Biopsy Data for Metastatic Breast CancerNovember 1, 2023 | businesswire.comFabric Genomics and DNAnexus Team Up to Improve Scale and Speed of Data Analysis for Genomic MedicineOctober 18, 2023 | msn.comBionano Genomics, Ultragenyx Pharmaceutical among healthcare moversSeptember 28, 2023 | tmcnet.comSGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug DiscoverySeptember 21, 2023 | msn.comBionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's What You Should KnowSeptember 3, 2023 | businesswire.comWatchmaker Genomics Announces Co-Exclusive License to Disruptive DNA Methylation Technology and Strategic Supply Agreements with Exact SciencesAugust 30, 2023 | marketwatch.comBionano Genomics Shares Rise 13% After Publication of CRISPR-Cas9 Genome Mapping Study in 'Nature Communications'August 10, 2023 | finance.yahoo.comDNAPrint Genomics, Inc. (DNAG)August 9, 2023 | bizjournals.comWhat's next for Phase Genomics after new receiving new grantsAugust 4, 2023 | msn.comBionano Genomics announces reverse stock splitJuly 25, 2023 | technews.tmcnet.comFore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening DataJuly 24, 2023 | msn.comYou can unlock secrets your DNA holds, but do you need to?June 15, 2023 | msn.comWhat the Largest-Ever Study of Primate DNA Reveals About OurselvesJune 2, 2023 | benzinga.comInvivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer ResearchMay 10, 2023 | chron.comDNA "reference guide" expanded to reflect human diversitySee More Headlines Receive DNAG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DNAPrint Genomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolOTCMKTS:DNAG CUSIPN/A CIKN/A Webwww.dnaprint.com Phone(941) 366-3400Fax941-952-9770Employees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jatin PatelExec. OfficerDr. Laurence A. Rubin M.D.FRCPC FACP, Exec. OfficerMr. Naz Jiwani BBACIRM, Exec. OfficerMs. Pauline GulaExec. OfficerMr. Zach GaskinExec. OfficerMs. Emanuela CharltonExec. OfficerMs. Lisa Tandy HerrenExec. OfficerMr. Scot AlicExec. OfficerMr. Shannon BoydExec. OfficerDr. Hector de Jesus Ruiz Ph.D. (Age 77)Exec. Officer More ExecutivesKey CompetitorsAffinity Energy and HealthOTCMKTS:ALGXYBioqualOTCMKTS:BIOQDeltagenOTCMKTS:DGENProtalexOTCMKTS:PRTXRedpoint BioOTCMKTS:RPBCView All Competitors DNAG Stock Analysis - Frequently Asked Questions How do I buy shares of DNAPrint Genomics? Shares of DNAG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DNAG) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DNAPrint Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
